Evolving peptides for oral intake
|Title:||Evolving peptides for oral intake||Authors:||Brayden, David James||Permanent link:||http://hdl.handle.net/10197/12014||Date:||11-May-2020||Online since:||2021-03-08T12:39:24Z||Abstract:||The delivery of therapeutic peptides via the oral route remains a great challenge for the pharmaceutical industry. Oral delivery is the most convenient administration route, as it leads to higher patient compliance than for sub-cutaneous and intra-muscular injections and, for some chronic diseases, to earlier adoption of treatment.||Type of material:||Journal Article||Publisher:||Springer||Journal:||Nature Biomedical Engineering||Volume:||4||Start page:||487||End page:||488||Keywords:||Drug delivery; Drug development; Gastrointestinal system; Molecular medicine||DOI:||10.1038/s41551-020-0559-0||Language:||en||Status of Item:||Peer reviewed||ISSN:||2157-846X||This item is made available under a Creative Commons License:||https://creativecommons.org/licenses/by-nc-nd/3.0/ie/|
|Appears in Collections:||Conway Institute Research Collection|
Veterinary Medicine Research Collection
Show full item record
If you are a publisher or author and have copyright concerns for any item, please email email@example.com and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.